At its booth at the Society of Nuclear Medicine meeting, nuclear medicine vendor SMV will feature images from recent clinical studies under way to validate new technologies ranging from artifact correction to high-energy coincidence detection imaging.In
At its booth at the Society of Nuclear Medicine meeting, nuclear medicine vendor SMV will feature images from recent clinical studies under way to validate new technologies ranging from artifact correction to high-energy coincidence detection imaging.
In cardiac imaging, the Twinsburg, OH, company will display the latest studies from its Transmission Attenuation Correction (TAC) sites. The sites are demonstrating the value of using TAC on its own and in conjunction with SMV's Stasis motion correction algorithm and Restore depth-dependent resolution recovery technique.
In the coincidence detection realm, SMV will show images from its Volumetric Coincidence Reconstruction (VCR) option, which received 510(k) clearance in March for the Vision FX-80 fixed 180 dual-head camera (SCAN 4/16/97). SMV is waiting for clearance of VCR for its variable-angle cameras, according to Bill Bishop, vice president of business development. SMV will emphasize VCR image quality enhancements with algorithms such as randoms correction.
On the workstation side, the PowerStation SPX and MPX computers will be displayed, with SMV's new Vision 4.1 software. The software includes increased protocol automation, better edge detection, and the addition of Transient Ischemic Dilitation (TID) to SMV's MultiDim 3-D quantification.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.